Effect of COVID-19 infection and vaccination on SARS-CoV-2 antibody titer change following ovarian stimulation: Prospective analysis of IVF outcomes DOI Creative Commons
So–Youn Shin, J. Kim, Ji Hyang Kim

et al.

Medicine, Journal Year: 2024, Volume and Issue: 103(11), P. e37349 - e37349

Published: March 15, 2024

The coronavirus disease 2019 (COVID-19) outbreak caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2) has affected various medical fields worldwide. However, relatively few studies have examined the impact of COVID-19 infection and vaccination on in vitro fertilization (IVF) outcomes changes antibody concentration follicular fluid (FF). A total 45 women were prospectively recruited assigned to 3 groups: uninfected non-vaccinated control group (Control group), infected (COVID + vaccinated (Vaccination group). Serum (FF) estradiol, progesterone, concentrations measured. There no statistical differences number retrieved oocytes (P = .291), mature .416), good-quality embryos .694) among groups. In group, BNT162b2 exhibited a significantly lower trigger-day serum estradiol/MII oocyte level (110.6 pg/mL) than other vaccines (289.5 .006). No .687) FF .108) noted Only statistically significant between vaccine subgroups .047). do not affect IVF outcomes. effect steroidogenesis SARS-CoV2 titer should be further investigated.

Language: Английский

Preoperative COVID-19 and Postoperative Mortality in Cancer Surgery: A South Korean Nationwide Study DOI Creative Commons
Jae‐Woo Ju, Soo‐Hyuk Yoon, Tak Kyu Oh

et al.

Annals of Surgical Oncology, Journal Year: 2024, Volume and Issue: unknown

Published: June 15, 2024

We evaluated the impact of preoperative COVID-19 on early postoperative mortality in patients undergoing time-sensitive cancer surgery.

Language: Английский

Citations

5

Effectiveness of Paxlovid, an Oral Antiviral Drug, Against the Omicron BA.5 Variant in Korea: Severe Progression and Death Between July and November 2022 DOI Creative Commons
Jong-Mu Kim, Min‐Gyu Yoo, Soon Jong Bae

et al.

Journal of Korean Medical Science, Journal Year: 2023, Volume and Issue: 38(27)

Published: Jan. 1, 2023

Paxlovid is an oral antiviral drug that received emergency use authorization in South Korea for the treatment of patients with mild-to-moderate coronavirus disease 2019 (COVID-19) on January 14, 2022. Since onset severe acute respiratory syndrome 2 pandemic, virus has continued to evolve. The emergence new variants raised concerns about possible reductions effectiveness vaccines and drugs. infected omicron variant subvariants not yet been determined. This study assessed at reducing risk severe/critical illness or death COVID-19 caused by subvariant BA.5.In this nationwide retrospective cohort study, data 8,902,726 were collected from four sources (the Drug Utilization Review database, Patient Information Management System, confirmed patient information, basic epidemiological investigation data) between July 1 November 30, Multivariable logistic regression analysis was conducted, adjustment age, sex, immunity (vaccination), comorbidities.A total 1,936,925 included analysis, including 420,996 treated Paxlovid, 1,515,959 Paxlovid. aged ≥ 60 years age associated significantly reduced (46.0%), rate (32.5%), its high, regardless vaccination status.Paxlovid effective due BA.5 infection, especially older patients, status. suggests COVID-19-related symptoms should be administered their status, reduce severity death.

Language: Английский

Citations

12

Disparities in COVID-19 vaccine coverage and risk factors among individuals with disabilities DOI
Hee Kyoung Choi, Boyoung Jeon, Euna Han

et al.

Disability and health journal, Journal Year: 2025, Volume and Issue: unknown, P. 101817 - 101817

Published: Feb. 1, 2025

Language: Английский

Citations

0

Persistent differences in the immunogenicity of the two COVID-19 primary vaccines series, modulated by booster mRNA vaccination and breakthrough infection DOI
Keon Young Lee, Kyoung‐Ho Song, Kyoung Hwa Lee

et al.

Vaccine, Journal Year: 2024, Volume and Issue: 42(19), P. 3953 - 3960

Published: May 9, 2024

Language: Английский

Citations

3

Effective Vaccination and Education Strategies for Emerging Infectious Diseases Such as COVID-19 DOI Creative Commons
Seong‐Heon Wie, Jaehun Jung, Woo Joo Kim

et al.

Journal of Korean Medical Science, Journal Year: 2023, Volume and Issue: 38(44)

Published: Jan. 1, 2023

Social isolation and control owing to coronavirus disease 2019 (COVID-19) are easing; however, concerns regarding new infectious diseases have not disappeared. Given epidemic experiences such as severe acute respiratory syndrome (SARS), the influenza pandemic, Middle East (MERS), COVID-19, it is necessary prepare for outbreak of situations in which large-scale vaccinations required. Although development vaccines against COVID-19 has contributed greatly overcoming concerning vaccine side effects from general public, including medical personnel, decreased confidence efficacy effects, present many challenges promoting educating future. In addition plans develop diseases, education promotion administer latest developments public. Moreover, efforts needed secure necessity, legitimacy, evidence rapid vaccination on a large scale at national level. It also carefully scientific bases explanatory statements so that public can easily understand them. This study aimed establish strategies may occur Many ways promote healthcare workers should be prepared ensure administered safely. Thus, safety based specific data clinical studies necessary.

Language: Английский

Citations

7

Magnitude and Duration of Serum Neutralizing Antibody Titers Induced by a Third mRNA COVID-19 Vaccination against Omicron BA.1 in Older Individuals DOI Creative Commons
Jun-Sun Park, Jaehyun Jeon, Jihye Um

et al.

Infection and Chemotherapy, Journal Year: 2024, Volume and Issue: 56(1), P. 25 - 25

Published: Jan. 1, 2024

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant (B.1.1.529) is dominating disease 2019 (COVID-19) worldwide. waning protective effect of available vaccines against the a critical public health issue. This study aimed to assess impact third COVID-19 vaccination on immunity SARS-CoV-2 BA.1 strain in older individuals.

Language: Английский

Citations

2

Establishment of Safety Monitoring System for Vaccines Not Included in the National Immunization Program in Korea DOI Creative Commons
Eliel Nham, Jin Gu Yoon, Min Joo Choi

et al.

Journal of Korean Medical Science, Journal Year: 2024, Volume and Issue: 39(5)

Published: Jan. 1, 2024

In Korea, there are no surveillance programs for vaccines that not included in the national immunization program (NIP), and vaccine safety monitoring adult population is inadequate. This study aimed to establish a system non-NIP adults.

Language: Английский

Citations

2

Pneumonia Prevalence Upon Chest Radiography According to Vaccination Status Among Patients Under 50 Years of Age With Coronavirus Disease 2019 DOI Creative Commons
Yong Shik Kwon, Sun Hyo Park, Hyun Jung Kim

et al.

Journal of Korean Medical Science, Journal Year: 2024, Volume and Issue: 39(6)

Published: Jan. 1, 2024

Coronavirus disease 2019 (COVID-19) vaccination is effective in preventing the transmission and progression. However, relatively mild course of omicron variant decrease antibodies over time after raise questions about effectiveness vaccination, especially young people. We compared prevalence pneumonia chest X-ray severity score according to status among patients < 50 years old with COVID-19.

Language: Английский

Citations

2

Correlation of geopolitics, education, democracy with COVID-19 vaccination rate DOI Creative Commons
Konstantine Chakhunashvili,

Davit G. Chakhunashvili,

Eka Kvirkvelia

et al.

BMC Public Health, Journal Year: 2024, Volume and Issue: 24(1)

Published: March 4, 2024

Abstract Introduction Vaccine hesitancy is an ongoing problem and determining the factors that increase vaccination rate in various countries of world might be useful for further implementation efficient public health policies negating anti-vaccination campaigns. Materials methods Human Development Index (HDI), Education (EI), Democracy (DI), COVID-19 rates, data were collected from sources such as UNDP - Reports, UNESCO Index, Economist Intelligence, WHO– Dashboard, Our World In Data, The Financial Times Dashboard. Statistical analysis Pearson correlation, linear regression analyses done to determine a relation between above-mentioned indices rates (1-dose, 2-dose, booster, combined). Results HDI had strongest positive correlation with (1-dose– r (181) = 0.632, p < 0.001, 2-dose– 0.671, booster– 0.718, combined– 0.703, 0.001). EI (177) 0.560, 0.599, 0.642, 0.626, 0.001), DI (163) 0.445, 0.479, 0.534, 0.508, well Geographic location η (Eta) 0.610 0.633 0.657, 0.645, 0.001) rates. Conclusion There strong EI.

Language: Английский

Citations

2

The potential role of perceived neighborhood social cohesion on COVID-19 vaccination uptake among individuals aged 50 and older: Results from the Korean Community Health Survey DOI Creative Commons
Younhee Kim, Min Kyung Lim

PLoS ONE, Journal Year: 2024, Volume and Issue: 19(10), P. e0312309 - e0312309

Published: Oct. 22, 2024

The COVID-19 pandemic highlighted the critical importance of vaccination in controlling infectious diseases. While previous research has identified social cohesion as a potential facilitator health behaviors, empirical studies exploring its direct impact on rates, especially across different age groups, remain limited. This cross-sectional study utilized data from 2021 Korean Community Health Survey, nationally representative survey conducted South Korea. analysis focused adults aged 50 and older, categorizing them into two groups (50–64 ≥65). We investigated association between perceived neighborhood status, for socio-economic concerns related to COVID-19. Statistical was using complex sample multiple logistic regression adjust confounders. included 135,352 participants, with an showing that group ≥65, higher levels were significantly associated increased uptake (aOR trust neighbors: 1.200, 95% CI: 1.058–1.362; aOR mutual assistance among 1.491, 1.312–1.695). Interestingly, these associations not significant 50–64 group. Additionally, satisfaction healthcare services both (aOR: 1.106, 1.004–1.219 50–64; aOR: 1.306, 1.160–1.471 Our findings suggest plays crucial role influencing older adults, particularly those 65 above. These results indicate policies aimed at enhancing may effectively improve elderly. Future should explore other assess causal relationships longitudinal studies.

Language: Английский

Citations

2